Dual Targeting of EZH2 and HDAC with Tazemetostat and Belinostat Promotes Immunogenicity in GC-DLBCL

Ricker, E. C., Estrella, B., Pazos, M. A., & Amengual, J. E. (2021). Dual Targeting of EZH2 and HDAC with Tazemetostat and Belinostat Promotes Immunogenicity in GC-DLBCL. Blood, 138(Supplement 1), 2410–2410. https://doi.org/10.1182/blood-2021-153460
Authors:
Edd Ricker
Brian Estrella
Manuel A. Pazos
Jennifer E. Amengual
Affiliated Authors:
Edd Ricker
Brian Estrella
Manuel A. Pazos
Jennifer E. Amengual
Columbia Affiliation:
Subjects:
Role of Histone Deacetylases in Cellular Regulation (OpenAlex Topic)
Epigenetic Modifications and Their Functional Implications (OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2021-153460
DOI:
10.1182/blood-2021-153460
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: